Built for device innovators by industry pioneers, the 15th Injectable Device Development Summit will unite 70+ senior leaders from pharma, biotech, and device service providers including Eli Lilly, Takeda, Sanofi, and Merck, to unpack how to enable flexible, patient-centric delivery platforms for high-viscosity, large-volume formulations. From advancing platform strategies to de-risking regulatory pathways and improving real-world usability, this is your essential forum to drive forward next-generation delivery systems that meet the needs of both regulators and patients.

See the event details here.